Funding Received
$144.9 Million in 4 Rounds from 6 Investors
Most Recent Funding
$50 Million Series C on July 18, 2013
Headquarters:
South San Francisco, CA
Description:
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Founders:
Jin-Long Chen
Categories:
Medical, Biotechnology
Website:
http://www.ngmbio.com

Company Details

Update
Founded:
2007
Contact:
Employees:
10 in CrunchBase

NGM Biopharmaceuticals, Inc. is a privately held drug discovery company committed to identifying transformational medicines that dramatically improve human health. Based on emerging human clinical and genetic observations, the Company has devised several innovative experimental approaches to discover new therapies for the treatment of metabolic and cardiovascular diseases. Our current focus is on the gastrointestinal endocrine system, with an aim to identify novel factors implicated in the pathogenesis of type 2 diabetes and the apparent resolution of this grievous disease in patients who have undergone gastric bypass surgery.

Board Members and Advisors (2)

Update

Investors (6)

Update

Offices/Locations (1)

Update
  • Office

    630 Gateway Blvd

    South San Francisco, CA 94080-7014

    USA

Past Team (1)

Update

Images (1)

Update
  • A015666a5ef687fc2f22a565a60efcb7